Compare Global X NASDAQ 100 Covered Call ETF (QYLD) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X NASDAQ 100 Covered Call ETF vs DENTSPLY SIRONA Inc — how do they compare? Global X NASDAQ 100 Covered Call ETF trades at $18.35, while DENTSPLY SIRONA Inc trades at $10.7 (market cap $2.14B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while Global X NASDAQ 100 Covered Call ETF pays none, and Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, DENTSPLY SIRONA Inc nearer its low. Which is the better fit depends on your goals.
| QYLD | XRAY | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $18.52 | $14.68 |
52-Week Low | $16.70 | $9.64 |
Market Cap | — | $2.14B |
Enterprise Value | — | $4.21B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QYLD trades at $18.37, up 0.05% with a bullish technical signal from moving averages. The ETF generates income through covered calls on the NASDAQ-100, providing an estimated 11-12% yield but limiting upside participation in strong bull markets. Recent dividend payments of $0.18-$0.19 per share demonstrate consistent income generation while the underlying index experiences volatility.
The outlook remains mixed - QYLD offers attractive monthly income for retirees but has historically underperformed the NASDAQ-100 during sustained rallies. Principal erosion risk exists as the strategy caps gains during market advances. Investors should weigh high yield against potential long-term capital appreciation sacrifice in tech-heavy markets.
XRAY trades at $10.99, down 3.43% on the day, reflecting ongoing pressure from declining revenues and negative profitability. The stock shows a bearish technical signal, with key support at $10. Recent Q2 2026 earnings beat estimates but sales fell 4.1%, highlighting persistent challenges in dental markets. Cash flow improved in 2025, yet net losses and high debt levels remain concerns.
The outlook is cautious; while analyst consensus suggests modest upside to a $12.50 target, weak margins, falling sales, and potential fiduciary scrutiny pose significant risks. Recovery depends on successful execution of the company's turnaround plan amid competitive and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
